Emergence Therapeutics Alternatives & Competitors
12 companies similar to Emergence Therapeutics — Emergence Therapeutics creates effective immuno-therapeutics to target Nectin-4...
Companies similar to Emergence Therapeutics
Mersana Therapeutics
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...
Araris Biotech AG
Building tomorrow's antibody-drug conjugates (ADCs)
Spirea
Elevating the Therapeutic Potential of ADCs in Cancer and Beyond with Our Unique Multivale...
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
Rival Readout
Competing with Emergence Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
Iksuda Therapeutics
Creating class-leading ADCs with enhanced tumor specificity
Pheon Therapeutics
Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...
Bicycle Therapeutics
Precision-Guided Therapeutics
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
NeoPhore Ltd
Discovering drugs that create neoantigens
Molecular Templates
Engineering the Next Generation of Therapeutics
ADC Therapeutics
Innovating Science. Inspiring Hope.
About Emergence Therapeutics
Emergence Therapeutics, established in 2019, is a prominent European biopharmaceutical company based in Germany. The company specializes in creating advanced antibody-drug conjugates (ADCs) targeting high-priority cancers, particularly through the innovation of effective immuno-therapeutics for Nectin-4 and other cance...
Manufacture and distribution of authentic medicines, LillyDirect online pharmacy services, Conducting and supporting clinical trials, Providing informational resources on various health conditions, Developing genetic medicine treatments
Patients with specific medical conditions, Healthcare providers, Individuals participating in clinical trials, Individuals seeking information on health conditions, Caregivers of patients with conditions like Alzheimer's
Immuno-therapeutics, Antibody-drug Conjugates, Nectin-4 Targeting, Cancer Treatment, Biopharmaceutical, Linker And Payload Technology, High-priority Cancers, Therapeutic Development, Oncology, Clinical Validation, Enfortumab Vedotin, Urothelial Cancer, Innovation In ADCs, Unmet Therapeutic Needs
B2B, B2B2B, B2B2C
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Emergence Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Emergence Therapeutics on 14 May 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.